← Open Payments lookup

PETER IGE: Open Payments

NPI 1164060943 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,318 in 53 payments from 10 companies in 2025. Trend: 2023 $1,193 · 2024 $1,578 · 2025 $1,318

Food & beverage: $1,318
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.25$474
Teva Pharmaceuticals USA, Inc.5$324
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$205
Alkermes, Inc.3$71
Otsuka America Pharmaceutical, Inc.3$52
Vanda Pharmaceuticals Inc.2$49
ABBVIE INC.3$47
Lundbeck LLC2$43
Almatica Pharma LLC1$31
IDORSIA PHARMACEUTICALS US INC1$22

Products named: INGREZZA, UZEDY, CAPLYTA, REXULTI, ARISTADA, FANAPT, VRAYLAR, LOREEV XR.

Industry payments across MD — which companies pay providers there.